Market Cap $3,789,391,228,742
24h Volume $99,364,936,957
BTC Market Cap $1,929,480,637,825
BTC Dominance 50.9%

Remme Live Price Update & Market Capitalization

Remme REM Rank #752

$0.0000571731 10.31%

Market Overview

Remme current market price is $0.0000571731 with a 24 hour trading volume of $282. The total available supply of Remme is 0 REM. It has secured Rank 752 in the cryptocurrency market with a marketcap of $0. The REM price is 10.31% down in the last 24 hours.

The volume-weighted average price of the Remme is $0.0000570308 in the last 24 hours. Live prices from all markets and coin market Capitalization. Stay up to date with the latest price movements. Check our coin stats data and see when there is an opportunity to buy or sell at best price in the market.

Buy Remme (REM)

Sell Remme (REM)

Remme Rank

752

Remme Price

$0.0000571731

VWAP (24h)

$0.0000570308

Price Change (24h)

10.31%

Market Cap

Trading Volume (24H)

$282

Circulating Supply

0 REM

Max Supply

(Not Available)

Cryptocurrency Remme Calculator

Want to convert more cryptocurrencies?

Use Crypto Calculator

Remme Historical Data Price Chart

Remme Markets Exchange Data

Compare live prices of Remme on top exchanges.

#	Exchange	Pair	Price	Volume (24h)	Volume (%)
	Gate	REM/USDT	$0.0000571759	$282	100%

Cryptocurrency Latest News & Updates

ETH/BTC pair hits YTD low as Bitcoin dominance surges

ETH/BTC hits its lowest level this year as Bitcoin soars to a new all-time high, fueling market dominance debates....

Crypto murder: Two more arrested in Montreal crypto influencer case

Two additional arrests have been made in the case of Kevin Mirshahi, a cryptocurrency influencer whose body was discovered in a Montreal park last month. Quebec provincial police announced that Darius Perry, 27, and Nackael Hickey, 25, face charges of…...

Nasdaq-listed antibiotics developer Acurx to put $1m in Bitcoin on balance sheet

Public biopharmaceutical company Acurx Pharmaceuticals said it plans to buy up to $1 million worth of Bitcoin to hold as a “treasury reserve asset.” Acurx Pharmaceuticals, a biopharmaceutical company developer new antibiotics for hard-to-treat bacterial infections, is set to purchase…...